Heidelberg Pharma AG

HPHA XETRA / Francfort Healthcare & Biotech Germany
2.90
3.20 %

Heidelberg Pharma AG specializes in the development of innovative cancer drugs, with a focus on antibody-drug conjugates.

Price history of Heidelberg Pharma AG
Price history of Heidelberg Pharma AG

Performance & Momentum

6 Months 19.83 %
1 Year 4.92 %
3 Years 47.08 %
5 Years 39.58 %

Similar stocks to Heidelberg Pharma AG

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone